Roche has said it plans to UK price its latest ... based on a price of £1,470 for 28 capsules. Although Novartis also offered a commercially confidential discount for Gilenya in order to get ...

Nestle's slumping share price is rattling shareholders and pension funds that have invested in the food giant, piling ...

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

Roche (RHHBY) announced that the Food and Drug Administration has approved a New Drug Application for an Evrysdi tablet for people living with ...

New 5mg tablet offers the same established efficacy and safety as the Evrysdi oral solution for individuals living with spinal muscular atrophy.

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Roche's $8 billion InterMune acquisition, disclosed a decade ago, is now being handed to a specialty pharmaceutical company.

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Amazon is offering a super beauty rush sale wherein you can buy all things skincare, makeup, and hair care at up to 60% off.

Cream moisturisers: These are thicker and richer than gels, containing a blend of humectants, emollients and often occlusives ...